NovoSeven

Partial Change Approval

Eptacog alfa (activated) (genetical recombination)

Approval Information

Brand NameNovoSeven

Generic NameEptacog alfa (activated) (genetical recombination)

ApprovedSeptember 2024

TypePartial Change Approval

Review Reports

English Review Report

PDF · 213.22 KB

Japanese Review Report

PDF · 1.40 MB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database